SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-053152
Filing Date
2023-04-28
Accepted
2023-04-28 17:10:00
Documents
6
Effectiveness Date
2023-04-28

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2313800d1_s8.htm S-8 51976
2 EXHIBIT 5.1 tm2313800d1_ex5-1.htm EX-5.1 9790
3 EXHIBIT 23.1 tm2313800d1_ex23-1.htm EX-23.1 1795
4 EX-FILING FEES tm2313800d1_ex-filingfees.htm EX-FILING FEES 23167
5 GRAPHIC tm2313800d1_ex5-1img001.jpg GRAPHIC 7831
6 GRAPHIC tm2313800d1_ex5-1img002.jpg GRAPHIC 3052
  Complete submission text file 0001104659-23-053152.txt   103073
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-271522 | Film No.: 23868190
SIC: 2834 Pharmaceutical Preparations